Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

BUY
$191.89 - $259.92 $4,797 - $6,498
25 Added 357.14%
32 $6,000
Q4 2022

Jan 25, 2023

BUY
$197.11 - $250.07 $1,379 - $1,750
7 New
7 $2,000
Q2 2021

Aug 13, 2021

SELL
$294.17 - $371.65 $40,889 - $51,659
-139 Closed
0 $0
Q2 2019

Jul 19, 2019

SELL
$123.4 - $148.55 $14,684 - $17,677
-119 Reduced 46.12%
139 $20,000
Q1 2019

Apr 08, 2019

BUY
$104.82 - $146.73 $27,043 - $37,856
258 New
258 $37,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sageworth Trust CO Portfolio

Follow Sageworth Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO with notifications on news.